Who is sponsoring NCT03869203?

NCT03869203 is sponsored by Yonsei University.

What drugs are being tested in NCT03869203?

Interventions in NCT03869203: Enhanced recovery after surgery (ERAS).

What condition does NCT03869203 study?

NCT03869203 studies Arthroplasty, Replacement, Knee, Hip.

Is NCT03869203 still recruiting?

NCT03869203 is currently status unknown. Last updated 10 May 2019.

Last reviewed 2019-05-10 · How we verify

NCT03869203

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Randomized Controlled Trial of Impact of Enhanced Recovery After Surgery(ERAS) for Outcomes of Total Knee and Hip Arthroplasty

Status unknown NA Last updated 10 May 2019

What this trial tests

NA trial testing Enhanced recovery after surgery (ERAS) in Arthroplasty, Replacement, Knee, Hip in 100 participants. Status unknown.

Timeline

10 May 2019

Primary endpoint
1 September 2020

1 September 2020

Quick facts

Lead sponsor	Yonsei University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	10 May 2019
Primary completion	1 September 2020
Estimated completion	1 September 2020
Sites	1 location across South Korea

Drugs / interventions tested

Enhanced recovery after surgery (ERAS)

Conditions studied

Arthroplasty, Replacement, Knee, Hip — all drugs for Arthroplasty, Replacement, Knee, Hip →

Sponsor

Yonsei University

Who can join

Adults 20 to 90, any sex, with Arthroplasty, Replacement, Knee, Hip. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Quality of recovery score(QoR40)
Time frame: 1 day before surgery
Before surgery, QoR40 questionnaires will be used to compare the quality of recovery after anesthesia. QoR40 is a 40 items quality of recovery score that has been validated in a diverse group of patients. It is comprised of five dimensions which are physical comfort (12 items), emotional state (9 items), physical independence (5 items), psychological support (7 items), and pain (7 items). Each ite
Quality of recovery score(QoR40)
Time frame: postoperative 1 day
After surgery, QoR40 questionnaires will be used to compare the quality of recovery after anesthesia. QoR40 is a 40 items quality of recovery score that has been validated in a diverse group of patients. It is comprised of five dimensions which are physical comfort (12 items), emotional state (9 items), physical independence (5 items), psychological support (7 items), and pain (7 items). Each item

Sponsor's own description

The purpose of this study is to analyze the effect of the ERAS(early recovery after surgery) protocol on total knee and hip arthroplasty compared to conventional standard protocol. Patients will be divided into two groups: ERAS protocol group and standard protocol group. On the day before the surgery, the patient group was randomly assigned by the researcher (research nurse) who did not participate in the surgical procedure. By comparing the clinical outcomes and quality of postoperative recovery of both groups, we could confirm the effect of ERAS protocol.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Enhanced recovery after surgery (ERAS)

Trials testing the same drug.

NCT06732635 — Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer · Phase 3 · completed
NCT03518463 — Enhanced Recovery After Surgery for Emergency Caesarean Deliveries · NA · completed

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03869203 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 10 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03869203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing